• SAR131675: VEGFR-3 Biology for Translational Research

  2026-09-22

  A thought-leadership analysis of SAR131675 as a selective VEGFR-3 inhibitor, covering its ATP-competitive mechanism, experimental validation, translational positioning, model-selection strategy, and limitations for cancer, lymphangiogenesis, angiogenesis, fibrosis, and kidney-disease research.

• CD80 mRNA: A Translational Lever for Costimulation

  2026-09-22

  Transient CD80 expression offers a controllable way to study antigen-presenting-cell costimulation and its effect on T-cell function. This thought-leadership article connects the clinical logic of mRNA-augmented CAR T-cell therapy with practical assay design using EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag), while clearly separating research hypotheses from clinical evidence.

• VZV gE Mutations Improve mRNA Vaccine Responses

  2026-09-21

  The reference study tested whether altering the carboxyl-terminal trafficking motifs of varicella-zoster virus glycoprotein E could improve the immunogenicity of LNP-formulated mRNA vaccines. Its combined C-terminal mutant produced the most consistent humoral and cellular responses, supporting antigen-trafficking engineering as a strategy for candidate varicella and zoster vaccines.

• Pretomanid and Dual Terminal Oxidase Inhibition

  2026-09-21

  The reference study identifies simultaneous inhibition of the cytochrome bcc:aa3 and cytochrome bd respiratory branches as a central feature of pretomanid activity against Mycobacterium tuberculosis. Its combination data support pairing pretomanid with telacebec and, in a triple regimen, ND-011992 to improve killing across replicating and antibiotic-tolerant populations while limiting resistance emergence.

• Pseudo-UTP for Reliable RNA Workflows

  2026-09-20

  Learn how Pseudo-UTP (SKU B7972) can improve the design, handling, and interpretation of in vitro-transcribed RNA workflows that feed into cell viability, proliferation, and cytotoxicity studies. This scenario-based guide separates product-backed specifications from laboratory validation steps so researchers can make reproducible, evidence-aware decisions.

• Mitoxantrone: Reliable Cell Assay Workflows

  2026-09-19

  Learn how Mitoxantrone SKU BA2039 can support reproducible viability, proliferation, cytotoxicity, and ABCG2-resistance experiments. This practical guide covers mechanism, DMSO formulation, assay controls, protocol optimization, data interpretation, and vendor selection.

• Radicicol: Hsp90 Inhibitor Workflow Guide

  2026-09-18

  Radicicol supports mechanistic studies spanning Hsp90 proteostasis, adipocyte differentiation, apoptosis, kinase ATP-site biology, and inflammatory signaling. This workflow guide pairs quantified product attributes with practical controls, dose-finding logic, and a careful bridge to mitochondrial senescence research.

• Metabolic Intervention Amplifies Ferroptosis and Cuproptosis

  2026-09-18

  The reference study develops a copper–tannic acid/liposome nanosystem that combines copper delivery with STF-31-mediated inhibition of glycolysis and NAD+ metabolism. By lowering ATP, NADPH, and glutathione-related defenses while restricting copper efflux, the strategy increases ferroptosis and cuproptosis susceptibility and supports antitumor immune activation.

• EGCG Workflows for Neuroprotection Research

  2026-09-17

  Use EGCG as a chemically defined comparator in oxidative-stress, apoptosis, cancer chemoprevention, and neurodegeneration workflows. A C. elegans study of Tapuy wine and lees shows why pairing biochemical measurements with functional phenotypes can reveal protection that a single assay misses.

• GSK621: AMPK Agonist for AML Metabolism

  2026-09-17

  GSK621 is a cell-permeable AMPK agonist for connecting energy sensing with leukemia survival, autophagy, lipid metabolism, and apoptosis. This workflow also shows how to use it as a mechanistic probe alongside the lysosomal 25-hydroxycholesterol–AMPK axis identified in macrophage immunometabolism.

• T7 RNA Polymerase for Cardiac RNA Assays

  2026-09-16

  T7 RNA Polymerase enables controlled production of RNA probes, standards, and functional transcripts from defined DNA templates. This guide connects the enzyme to HEY2–mitochondrial research, with practical setup, optimization, troubleshooting, and clear limits for adjacent applications such as RNA vaccine production.

• Viperin–nsp8 Disruption of Coronavirus Replication

  2026-09-16

  A 2026 study identifies a coronavirus-restriction mechanism in which viperin binds nsp8 and interferes with replication-transcription complex assembly and RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the work expands viperin biology beyond ddhCTP-mediated chain termination and highlights a conserved protein interface relevant to antiviral drug development.

• NIH/3T3 Cells: Recovery, Culture, and QC

  2026-09-15

  NIH/3T3 Cells provide an adherent mouse fibroblast starting material for controlled recovery, expansion, cell transfection studies, viral proliferation research, and oncogene research. This guide translates the product dossier into a practical workflow while clarifying that the cells are for research use and do not establish clinical utility, viral permissiveness, or quantitative assay performance.

• Cy5-UTP for Axonal RNA Trafficking Studies

  2026-09-15

  Cy5-UTP enables direct fluorescent RNA probe synthesis for spatial studies of axonal RNP biology. This article connects Cyanine 5-uridine triphosphate labeling with the ANXA7–dynein–TIA1 trafficking mechanism while distinguishing localization assays from live transport measurements.

• Phalloidin B7678: Practical F-Actin Guide

  2026-09-14

  Phalloidin B7678 is a cyclic heptapeptide toxin used to stabilize and visualize filamentous actin in fixed, permeabilized cells, tissue sections, and cell-free assays. It is intended for endpoint cytoskeleton visualization, not live-cell imaging or experiments requiring reversible actin remodeling.

8333 records 1/556 page Next 12345 下5页 Last page